Epilepsy Trial, Recruiting NCT06934356 Sponsor: Yale University Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06934356
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthy adults (age 18 and up):

  • You have normal vision, even if you need contact lenses or glasses to see well (soft contact lenses only)
  • You have normal hearing and do not need a hearing aid

For epilepsy patients who have thalamic electrodes (age 13 and up):

  • You have normal vision, with or without corrective lenses
  • You are able to give your own consent to participate in the trial

For epilepsy patients who have thalamic electrodes (age 18 and up):

  • You have normal vision, with or without corrective lenses
  • If you are a woman who could become pregnant, you have a negative pregnancy test and are using reliable birth control, have had a surgical procedure to prevent pregnancy, or have been through menopause for at least two years
  • You are able to give your own consent to participate in the trial

Who may not be able to join:

For healthy adults (age 18 and up):

  • You have a past or current diagnosis of a psychiatric or neurological condition (such as a mental health or brain/nerve disorder)
  • You need hard contact lenses or glasses to see normally, as these can interfere with eye-tracking measurements
  • You are pregnant, or you have metal objects inside or on your body that cannot be removed, as these make MRI scans unsafe

For epilepsy patients who have thalamic electrodes (age 13 and up):

  • Your vision is severely impaired even with glasses or contact lenses, making it hard to see the visual parts of the study
  • You have a level of cognitive (thinking or understanding) difficulty that would prevent you from completing the tasks in the study (confirm with trial site)
  • You are unable to give your own consent to participate

For epilepsy patients who have thalamic electrodes (age 18 and up):

  • Your vision is severely impaired even with glasses or contact lenses, making it hard to see the visual parts of the study
  • You have a level of cognitive (thinking or understanding) difficulty that would prevent you from completing the tasks in the study (confirm with trial site)
  • You are unable to give your own consent to participate
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hal Blumenfeld, MD, Phd, Yale University

Phone: (203) 785-3865

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
13 October 2025
Est. completion
1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Subcortical event-related signals; Perceptual Sensitivity; Activity changes; Functional connectivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov